spacer
Eyepea Management Services - Intellectual Property ServicesIntellectual Property Management Service. A Registered Trademark Agent » Bookmark this page
IP Services
Home
Trademark Search
Trademark Registration
Trademark Renewal
Trademark Assignment
Request for Service
IP Resources
Intellectual Property
Trademark
Copyright
Patent
Book Store
Latest IP News
TM Common Terms
Nice Classification
About Eyepea
Contact Us
About Us
 
IP & Trademark Related Book List
Keyword    (e.g. how to patent)

Amgen and Biovitrum sign metobolic disease license agreement. : An article from: BIOTECH Patent News


Amgen and Biovitrum sign metobolic disease license agreement. : An article from: BIOTECH Patent News Amgen and Biovitrum sign metobolic disease license agreement. : An article from: BIOTECH Patent News

Offer Price: USD $5.95

See Latest Price & Discount

Binding: Digital
Publication Date: 2003-09-01
Publisher:Biotech Patent News


Editorial Reviews:

Book Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on September 1, 2003. The length of the article is 634 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Amgen and Biovitrum sign metobolic disease license agreement.
Publication:BIOTECH Patent News (Newsletter)
Date: September 1, 2003
Publisher: Biotech Patent News
Volume: 17 Issue: 9

Distributed by Thomson Gale
spacer

Eyepea Management Services is now part of Intellect Front. Based in Malaysia, Singapore, and U.S., Intellect Front specializes in trademark & intellectual property portfolio management.
© 2008 Intellect Front. All Rights Reserved. Privacy Policy
Powered by Genuine Technology
spacer